Pat. | Age | Gender | Eye | Initial stage / BCVA | Treatment | FU (years) | Final BCVA |
---|---|---|---|---|---|---|---|
1 | 29 | M | L | 2a / 1.0 | Laser | 37 | 1.0 |
2 | 16 | F | L | 2a / 0.8 | Laser + cryo | 32 | 0.9 |
3 | 33 | M | L | 2a / 0.8 | Laser | 32 | 0.8 |
4 | 18 | M | L | 2a / 0.8 | Laser | 41 | 1.0 |
5 | 5 | M | R | 2b / 0.1 | Laser + cryo | 17 | 0.3 |
6 | 18 | M | L | 2b / 0.06 | Laser + cryo | 36 | 0.04 |
7 | 8 | F | R | 2b / 0.04 | Laser + cryo | 33 | 0.04 |
8 | 19 | M | R | 2b / 0.3 | Laser | 32 | 0.4 |
9 | 19 | F | L | 2b / 0.02 | Laser | 29 | 0.02 |
10 | 21 | M | L | 2b / 0.2 | Laser + cryo | 31 | 0.1 |
11 | 20 | F | R | 2b / 0.3 | Laser + cryo | 37 | 0.02 |
11 | 20 | F | L | 3b / PL | Enucleation | ||
12 | 16 | M | R | 3b / PL | CB-cryo | 30 | NPL |
13 | 8 | M | R | 3b / PL | None | 18 | NPL |